I am impressed by the authenticity and humility with which the leadership approaches DE&I, and its willingness to learn.
Rohini Anand
Strategic DE&I Advisor and Sanofi DE&I Board Member
Our DE&I board
With three of the most influential, independent voices in DE&I today, the board will:
-
hold us to account
-
ensure we deliver on our DE&I commitments
-
monitor progress on our 2025 targets
-
advise on how to accelerate the company’s DE&I impact.
Our DE&I focus
Our strategy is built on three pillars:
-
Building representative leadership
-
Creating a work environment where employees can be their best selves
-
Engaging with the company’s diverse communities.
Meet the board members
In addition to three prestigious external advisors, the DE&I Board also features our CEO, five Sanofi Executive Committee members, and our Chief Diversity Officer. Our employees are represented as Global Employee Resource Group (ERG) leads.
Rohini Anand, DE&I board member
Caroline Casey, DE&I board member
Elisabeth Moreno, DE&I board member
Spreading values to inspire
External board advisors
Dr. Rohini Anand
Caroline Casey
Elisabeth Moreno
Internal board members
Paul Hudson
Natalie Bickford
Olivier Charmeil
Jake Prodoehl
Global Project Manager, Tolebrutinib - Global Lead, Pride+ ERG
Roy Papatheodorou
Myles Thomas
Customer Engagement Manager, US
Thomas Triomphe
Raj Verma
Our local DE&I teams
Our DE&I strategy is constantly evolving and we’re listening and learning as we progress on our journey.
Our Board and Global Employee Resource Groups work together to bring the outside in, and give our people an even stronger voice.
